The safe and effective use of fowlpox virus as a vector for poultry vaccines.
The safety and efficacy of a fowlpox-Newcastle disease vaccine were evaluated by in vitro and in vivo methods. Genetic and phenotypic stability following cell culture and chick passage were demonstrated. The safety characteristics of the recombinant virus equalled or exceeded those of the parent fowlpox virus, as determined by lack of shed and spread to contacts, failure to revert to virulence following passage in chicks and innocuity in other avian species. The fowlpox-Newcastle Disease virus effectively immunized against virulent fowlpox challenge and virulent Newcastle disease challenge (intramuscular or intra-ocular administration). These results indicate that the recombinant FPV/NDV virus is a safe and effective vaccine for poultry.
McMillen
J K
JK
SyntroVet Incorporated, Lenexa, KS.
Cochran
M D
MD
Junker
D E
DE
Reddy
D N
DN
Valencia
D M
DM
D000818:Animals; D002645:Chickens; D003370:Coturnix; D003673:Defective Viruses / Q000235:genetics / Q000276:immunology*; D005123:Eye; D005587:Fowlpox virus / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity; D005822:Genetic Vectors; D015707:HN Protein / Q000276:immunology; D007267:Injections; D007273:Injections, Intramuscular; D009521:Newcastle Disease / Q000517:prevention & control*; D009522:Newcastle disease virus / Q000276:immunology*; D010641:Phenotype; D011201:Poultry Diseases / Q000517:prevention & control*; D012449:Safety; D013045:Species Specificity; D014422:Turkeys; D014611:Vaccination / Q000662:veterinary*; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic / Q000009:adverse effects / Q000276:immunology; D014760:Viral Fusion Proteins / Q000276:immunology; D014765:Viral Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology; D014774:Virulence
D015707:HN Protein; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic; D014760:Viral Fusion Proteins; D014765:Viral Vaccines